Recce’s Phase 2 ABSSSI Clinical Trial is on Track and Producing Outstanding Results
There are encouraging signs from Recce Pharmaceuticals‘ (ASX:RCE) Phase 2 ABSSSI Clinical Trial (Acute Bacterial Skin and Skin Structure Infections).…
Read MoreDominos Pizza Enterprises (ASX:DMP): Will it remain in the doldrums in FY25 as it transitions away from Don Meij?
Dominos Pizza Enterprises (ASX:DMP) is stuck in a difficult position. Its share price is barely a quarter of its 2021…
Read MoreMaas Group (ASX:MGH) … Why investors should keep a keen eye on it in FY25!
It is a tough time to be a construction company, but Maas Group (ASX:MGH) hasn’t fared that bad all things…
Read More